(BLX) Foreign Trade Bank of Latin - Ratings and Ratios
Trade Finance, Export Lending, Import Credit, Asset Secured
BLX EPS (Earnings per Share)
BLX Revenue
| Risk via 10d forecast | |
|---|---|
| Volatility | 26.0% |
| Value at Risk 5%th | 40.6% |
| Reward | |
|---|---|
| Sharpe Ratio | 1.18 |
| Alpha Jensen | 24.67 |
| Character | |
|---|---|
| Hurst Exponent | 0.513 |
| Beta | 0.843 |
| Drawdowns 3y | |
|---|---|
| Max DD | 21.01% |
| Mean DD | 4.04% |
Description: BLX Foreign Trade Bank of Latin August 13, 2025
Foreign Trade Bank of Latin America Inc (BLX) is a Panamanian common stock operating in the Specialized Finance sub-industry. The bank provides financial services to Latin American countries, facilitating international trade.
To evaluate BLXs performance, key metrics include Return on Equity (RoE) of 15.63%, indicating the banks ability to generate profits from shareholders equity. The Price-to-Earnings (P/E) ratio of 7.02 suggests that the stock is undervalued relative to its earnings. Market capitalization stands at $1.446 billion, reflecting the companys size and investor confidence.
Economic drivers influencing BLXs performance include Latin Americas trade dynamics, regional economic growth, and the banks ability to navigate complex financial transactions. Key Performance Indicators (KPIs) to monitor include net interest margin, loan growth, and asset quality. The banks exposure to emerging markets and trade finance opportunities positions it for potential growth, driven by increasing demand for financial services in the region.
Investors should consider the banks competitive positioning, risk management practices, and regulatory environment. BLXs beta of 0.84 indicates relatively lower volatility compared to the broader market. The stocks current price is near its 52-week high, suggesting strong recent performance. Average trading volume is around 131,150 shares, indicating moderate liquidity.
BLX Stock Overview
| Market Cap in USD | 1,641m |
| Sub-Industry | Specialized Finance |
| IPO / Inception | 1992-09-24 |
| Return 12m vs S&P 500 | 17.8% |
| Analyst Rating | 4.50 of 5 |
BLX Dividends
| Dividend Yield | 5.67% |
| Yield on Cost 5y | 24.15% |
| Yield CAGR 5y | 15.21% |
| Payout Consistency | 81.9% |
| Payout Ratio | 41.6% |
BLX Growth Ratios
| CAGR | 48.49% |
| CAGR/Max DD Calmar Ratio | 2.31 |
| CAGR/Mean DD Pain Ratio | 12.01 |
| Current Volume | 126.6k |
| Average Volume | 126.6k |
Piotroski VR‑10 (Strict, 0-10) 2.0
| Net Income (222.4m TTM) > 0 and > 6% of Revenue (6% = 41.5m TTM) |
| FCFTA 0.01 (>2.0%) and ΔFCFTA 1.76pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -754.5% (prev -598.9%; Δ -155.6pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.01 (>3.0%) and CFO 143.3m <= Net Income 222.4m (YES >=105%, WARN >=100%) |
| Net Debt (3.56b) to EBITDA (225.1m) ratio: 15.79 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.30 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (37.2m) change vs 12m ago 1.21% (target <= -2.0% for YES) |
| Gross Margin 43.36% (prev 50.57%; Δ -7.22pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 5.78% (prev 7.24%; Δ -1.46pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 0.44 (EBITDA TTM 225.1m / Interest Expense TTM 381.3m) >= 6 (WARN >= 3) |
Altman Z'' -2.25
| (A) -0.42 = (Total Current Assets 2.19b - Total Current Liabilities 7.40b) / Total Assets 12.50b |
| (B) 0.07 = Retained Earnings (Balance) 891.3m / Total Assets 12.50b |
| (C) 0.01 = EBIT TTM 167.4m / Avg Total Assets 11.95b |
| (D) 0.15 = Book Value of Equity 1.62b / Total Liabilities 10.85b |
| Total Rating: -2.25 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 57.21
| 1. Piotroski 2.0pt = -3.0 |
| 2. FCF Yield 4.47% = 2.24 |
| 3. FCF Margin 20.27% = 5.07 |
| 4. Debt/Equity 2.16 = 0.53 |
| 5. Debt/Ebitda 15.79 = -2.50 |
| 6. ROIC - WACC (= -2.37)% = -2.96 |
| 7. RoE 15.42% = 1.28 |
| 8. Rev. Trend 27.60% = 2.07 |
| 9. EPS Trend 89.60% = 4.48 |
What is the price of BLX shares?
Over the past week, the price has changed by +3.22%, over one month by -0.47%, over three months by +0.82% and over the past year by +36.01%.
Is Foreign Trade Bank of Latin a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of BLX is around 61.16 USD . This means that BLX is currently undervalued and has a potential upside of +38.68% (Margin of Safety).
Is BLX a buy, sell or hold?
- Strong Buy: 1
- Buy: 1
- Hold: 0
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the BLX price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 55.5 | 25.9% |
| Analysts Target Price | 55.5 | 25.9% |
| ValueRay Target Price | 65.9 | 49.5% |
BLX Fundamental Data Overview November 11, 2025
P/E Trailing = 7.4333
P/S = 5.3201
P/B = 1.1836
P/EG = 1.58
Beta = 0.843
Revenue TTM = 691.3m USD
EBIT TTM = 167.4m USD
EBITDA TTM = 225.1m USD
Long Term Debt = 2.70b USD (from longTermDebt, last fiscal year)
Short Term Debt = 139.4m USD (from shortTermDebt, last quarter)
Debt = 3.56b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.56b USD (from netDebt column, last quarter)
Enterprise Value = 3.13b USD (1.64b + Debt 3.56b - CCE 2.06b)
Interest Coverage Ratio = 0.44 (Ebit TTM 167.4m / Interest Expense TTM 381.3m)
FCF Yield = 4.47% (FCF TTM 140.1m / Enterprise Value 3.13b)
FCF Margin = 20.27% (FCF TTM 140.1m / Revenue TTM 691.3m)
Net Margin = 32.18% (Net Income TTM 222.4m / Revenue TTM 691.3m)
Gross Margin = 43.36% ((Revenue TTM 691.3m - Cost of Revenue TTM 391.6m) / Revenue TTM)
Gross Margin QoQ = 100.0% (prev 39.23%)
Tobins Q-Ratio = 0.25 (Enterprise Value 3.13b / Total Assets 12.50b)
Interest Expense / Debt = 3.56% (Interest Expense 126.7m / Debt 3.56b)
Taxrate = 21.0% (US default 21%)
NOPAT = 132.3m (EBIT 167.4m * (1 - 21.00%))
Current Ratio = 0.30 (Total Current Assets 2.19b / Total Current Liabilities 7.40b)
Debt / Equity = 2.16 (Debt 3.56b / totalStockholderEquity, last quarter 1.65b)
Debt / EBITDA = 15.79 (Net Debt 3.56b / EBITDA 225.1m)
Debt / FCF = 25.38 (Net Debt 3.56b / FCF TTM 140.1m)
Total Stockholder Equity = 1.44b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.78% (Net Income 222.4m / Total Assets 12.50b)
RoE = 15.42% (Net Income TTM 222.4m / Total Stockholder Equity 1.44b)
RoCE = 4.04% (EBIT 167.4m / Capital Employed (Equity 1.44b + L.T.Debt 2.70b))
RoIC = 2.44% (NOPAT 132.3m / Invested Capital 5.42b)
WACC = 4.81% (E(1.64b)/V(5.20b) * Re(9.12%) + D(3.56b)/V(5.20b) * Rd(3.56%) * (1-Tc(0.21)))
Discount Rate = 9.12% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.94%
[DCF Debug] Terminal Value 65.74% ; FCFE base≈140.1m ; Y1≈92.0m ; Y5≈42.1m
Fair Price DCF = 24.22 (DCF Value 696.1m / Shares Outstanding 28.7m; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: 89.60 | EPS CAGR: 22.23% | SUE: 4.0 | # QB: 5
Revenue Correlation: 27.60 | Revenue CAGR: 17.26% | SUE: 4.0 | # QB: 9
Additional Sources for BLX Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle